Literature DB >> 18496755

Influence of incorporation methods on partitioning behavior of lipophilic drugs into various phases of a parenteral lipid emulsion.

Warisada Sila-on1, Nontima Vardhanabhuti, Boonsri Ongpipattanakul, Poj Kulvanich.   

Abstract

The purpose of this study was to investigate the effect of drug incorporation methods on the partitioning behavior of lipophilic drugs in parenteral lipid emulsions. Four lipophilic benzodiazepines, alprazolam, clonazepam, diazepam, and lorazepam, were used as model drugs. Two methods were used to incorporate drugs into an emulsion: dissolving the compound in the oil phase prior to emulsification (de novo emulsification), and directly adding a concentrated solution of drug in a solubilizer to the emulsion base (extemporaneous addition). Based on the molecular structures and determination of the oil and aqueous solubilities and the partition coefficients of the drugs, the lipophilicity was ranked as diazepam > clonazepam > lorazepam > alprazolam. Ultracentrifugation was used to separate the emulsion into four phases, the oil phase, the phospholipid-rich phase, the aqueous phase and the mesophase, and the drug content in each phase was determined. Partitioning of diazepam, which has the highest lipophilicity and oil solubility among the four drugs, was unaffected by the drug incorporation method, with both methods giving a high proportion of drug in the inner oil phase and the phospholipid-rich phase, compared to the aqueous phase and mesophase. Partitioning of the less lipophilic drugs (alprazolam, clonazepam, and lorazepam) in the phases of the emulsion system was dependent on the method of incorporation and the drug solubility properties. Emulsions of the three drugs prepared by de novo emulsification exhibited higher drug localization in the phospholipid-rich phase compared to those made by extemporaneous addition. With the latter method, the drugs tended to localize in the outer aqueous phase and mesophase, with less deposition in the phospholipid-rich phase and no partitioning into the inner oil phase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18496755      PMCID: PMC2976948          DOI: 10.1208/s12249-008-9089-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  12 in total

1.  Partition of antimicrobial additives in an intravenous emulsion and their effect on emulsion physical stability.

Authors:  J Han; C Washington
Journal:  Int J Pharm       Date:  2004-12-10       Impact factor: 5.875

2.  Physico-chemical characterization of Intralipid emulsions.

Authors:  M Rotenberg; M Rubin; A Bor; D Meyuhas; Y Talmon; D Lichtenberg
Journal:  Biochim Biophys Acta       Date:  1991-11-27

3.  Pharmaceutical characterization of commercially available intravenous fat emulsions: estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy.

Authors:  H Komatsu; A Kitajima; S Okada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1995-08       Impact factor: 1.645

Review 4.  Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization.

Authors:  S Benita; M Y Levy
Journal:  J Pharm Sci       Date:  1993-11       Impact factor: 3.534

5.  Structural studies of commercial fat emulsions used in parenteral nutrition.

Authors:  J Li; K D Caldwell
Journal:  J Pharm Sci       Date:  1994-11       Impact factor: 3.534

6.  Gamma irradiation effects on stability of poly(lactide-co-glycolide) microspheres containing clonazepam.

Authors:  L Montanari; F Cilurzo; L Valvo; A Faucitano; A Buttafava; A Groppo; I Genta; B Conti
Journal:  J Control Release       Date:  2001-08-10       Impact factor: 9.776

7.  The effect of surface charge and partition coefficient on the chemical stability of solutes in O/W emulsions.

Authors:  Nongnuch Pongcharoenkiat; Ganesan Narsimhan; Robert T Lyons; Stanley L Hem
Journal:  J Pharm Sci       Date:  2002-02       Impact factor: 3.534

8.  Determination of methylparaben in o/w emulsions by solid-phase extraction and high-performance liquid chromatography.

Authors:  Nongnuch Pongcharoenkiat; Arunee Wittayanukulluk; Stanley L Hem
Journal:  J Cosmet Sci       Date:  2003 Jan-Feb       Impact factor: 0.948

9.  Physicochemical characterization of a model intravenous oil-in-water emulsion.

Authors:  K Westesen; T Wehler
Journal:  J Pharm Sci       Date:  1992-08       Impact factor: 3.534

10.  Solubilization and stabilization of an anti-HIV thiocarbamate, NSC 629243, for parenteral delivery, using extemporaneous emulsions.

Authors:  R G Strickley; B D Anderson
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

View more
  5 in total

Review 1.  Injectable lipid emulsions-advancements, opportunities and challenges.

Authors:  Ketan Hippalgaonkar; Soumyajit Majumdar; Viral Kansara
Journal:  AAPS PharmSciTech       Date:  2010-10-26       Impact factor: 3.246

2.  Application of Ultra-Centrifugation and Bench-Top 19F NMR for Measuring Drug Phase Partitioning for the Ophthalmic Oil-in-Water Emulsion Products.

Authors:  Xinyi Wang; Sharadrao M Patil; David A Keire; Xiaoming Xu; Kang Chen
Journal:  AAPS PharmSciTech       Date:  2018-03-02       Impact factor: 3.246

3.  A Simple and Noninvasive DOSY NMR Method for Droplet Size Measurement of Intact Oil-In-Water Emulsion Drug Products.

Authors:  Sharadrao M Patil; Vincent Li; Jiangnan Peng; Darby Kozak; Jin Xu; Bing Cai; David A Keire; Kang Chen
Journal:  J Pharm Sci       Date:  2018-10-03       Impact factor: 3.534

4.  Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye.

Authors:  Jayaganesh V Natarajan; Sujay Chattopadhyay; Marcus Ang; Anastasia Darwitan; Selin Foo; Ma Zhen; Magdalene Koo; Tina T Wong; Subbu S Venkatraman
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

5.  Molecular-trapping in Emulsion's Monolayer: A New Strategy for Production and Purification of Bioactive Saponins.

Authors:  Titus C Obasi; Radu Moldovan; Anca Toiu; Cornelia Braicu; Ede Bodoki; Ioana Berindan-Neagoe; Ilioara Oniga; Robert Sandulescu; Radu Oprean
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.